1. Tsujino, Takuya, Takai, Tomoaki, Hinohara, Kunihiko, Kibel, Adam S, Jia, Li. 2023. CRISPR screens reveal genetic determinants of PARP inhibitor sensitivity and resistance in prostate cancer. In Nature communications, 14, 252. doi:10.1038/s41467-023-35880-y. https://pubmed.ncbi.nlm.nih.gov/36650183/
2. Guo, Zhiting, Liu, Fahui, Gong, Qiming. 2022. Integrative pan-cancer landscape of MMS22L and its potential role in hepatocellular carcinoma. In Frontiers in genetics, 13, 1025970. doi:10.3389/fgene.2022.1025970. https://pubmed.ncbi.nlm.nih.gov/36276962/
3. Savci-Heijink, C Dilara, Halfwerk, Hans, Koster, Jan, van de Vijver, Marc J. 2016. A novel gene expression signature for bone metastasis in breast carcinomas. In Breast cancer research and treatment, 156, 249-59. doi:10.1007/s10549-016-3741-z. https://pubmed.ncbi.nlm.nih.gov/26965286/
4. Luo, Qiyu, He, Wenwu, Mao, Tianqin, Xu, Chuan, Han, Yongtao. 2021. MMS22L Expression as a Predictive Biomarker for the Efficacy of Neoadjuvant Chemoradiotherapy in Oesophageal Squamous Cell Carcinoma. In Frontiers in oncology, 11, 711642. doi:10.3389/fonc.2021.711642. https://pubmed.ncbi.nlm.nih.gov/34660277/
5. Kikuchi, Naoki, Moreland, Ethan, Homma, Hiroki, Generozov, Edward V, Ahmetov, Ildus I. 2021. Genes and Weightlifting Performance. In Genes, 13, . doi:10.3390/genes13010025. https://pubmed.ncbi.nlm.nih.gov/35052366/
6. Nguyen, Minh-Hue, Ueda, Koji, Nakamura, Yusuke, Daigo, Yataro. 2012. Identification of a novel oncogene, MMS22L, involved in lung and esophageal carcinogenesis. In International journal of oncology, 41, 1285-96. doi:10.3892/ijo.2012.1589. https://pubmed.ncbi.nlm.nih.gov/22895565/
7. Wendt, Frank R, Pathak, Gita A, Singh, Kritika, Davis, Lea K, Polimanti, Renato. 2022. Sex-Specific Genetic and Transcriptomic Liability to Neuroticism. In Biological psychiatry, 93, 243-252. doi:10.1016/j.biopsych.2022.07.019. https://pubmed.ncbi.nlm.nih.gov/36244801/
8. O'Connell, Brenda C, Adamson, Britt, Lydeard, John R, Elledge, Stephen J, Harper, J Wade. 2010. A genome-wide camptothecin sensitivity screen identifies a mammalian MMS22L-NFKBIL2 complex required for genomic stability. In Molecular cell, 40, 645-57. doi:10.1016/j.molcel.2010.10.022. https://pubmed.ncbi.nlm.nih.gov/21055985/
9. Piwko, Wojciech, Olma, Michael H, Held, Michael, Gerlich, Daniel W, Peter, Matthias. 2010. RNAi-based screening identifies the Mms22L-Nfkbil2 complex as a novel regulator of DNA replication in human cells. In The EMBO journal, 29, 4210-22. doi:10.1038/emboj.2010.304. https://pubmed.ncbi.nlm.nih.gov/21113133/
智鼠故事 
